MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
Dr van Harten explains the work of the Excellence Designation System carried out as part of the EurocanPlatform project work package dealing with the ‘Quality assessment, accreditation and metrics’ of European Comprehensive Cancer Centres (CCCs), which are institutions in which care and prevention is integrated with research and education.
EurocanPlatform is an EC funded project bringing together 28 European cancer Institutions and organisations to work together in a unique collaboration. The centres are sharing infrastructures and collaborating on projects to help advance cancer research and treatment.
He looks at the criteria used in this system, the methods used to develop it and the challenges involved in dealing with large numbers of stakeholders.
Watch this video on the highlights of the project.
MCED blood test demonstrates high specificity, strong predictive value, and increased early cancer detection
Expectations and priorities of older patients with cancer: the PRIORITY multicenter cohort study
WCI's role in the prevention of tobacco related cancer among Beedi rolling women in India
Alternative livelihood training programme for rural women who are employed in the tobacco industry in India
ESMO 2024: Highlights and analysis
Assessment of suicide risk in cancer patients
Cancer journeys: Research from India
Depression in cancer
Managing 'fear of recurrence' of cancer patients